Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 11;16(18):2564.
doi: 10.3390/polym16182564.

Efficacy and Safety of Poly-l-Lactic Acid in Facial Aesthetics: A Systematic Review

Affiliations
Review

Efficacy and Safety of Poly-l-Lactic Acid in Facial Aesthetics: A Systematic Review

Roberta Signori et al. Polymers (Basel). .

Abstract

The primary objective of this systematic review study was to investigate the effectiveness, durability, and adverse events of PLLA treatment for aesthetic indications. The search strategy was performed in MEDLINE (Ovid). The electronic literature search of five databases was performed, from the inception of the databases until the 12th of February 2024. This was to identify randomized clinical trials that assessed PLLA treatment in adult individuals exhibiting facial aging and/or facial lipoatrophy. Risk of bias was assessed using the Cochrane Risk-of-Bias Tool for Randomized Trials (RoB 2). Eleven RCTs out of 1467 identified citations were included. Four studies showed increased dermal thickness, significant improvement in facial lipoatrophy severity and aesthetic clinical scores, after PLLA treatment with its effects sustained for at least 25 months. Two studies demonstrated the superiority of PLLA over injectable human collagen. Also, three studies showed positive results favoring PLLA when compared with PH gel in lipoatrophy severity, transepidermal water loss, skin quality, elasticity, and patient satisfaction. All adverse events were mild-to-moderate in intensity, and the main ones worth noting were bruising, hematoma, tenderness, nodules, and edema. Five out of eleven studies were considered having high risk of bias. The evidence on the effectiveness and safety of PLLA for facial rejuvenation is of low quality; thus, the reported high effectiveness, safety, and long-lasting effects for this purpose should be further investigated.

Keywords: Poly-l-lactic acid; biostimulator; facial aesthetics; systematic review.

PubMed Disclaimer

Conflict of interest statement

Authors A.C.C and A.P.B. are speakers for GALDERMA S.A. Brazil. All other authors declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.

Figures

Figure 1
Figure 1
The figure illustrates the PRISMA flow chart of the database search strategy.

References

    1. Christen M.-O. Collagen stimulators in body applications: A review focused on poly-l-lactic acid (PLLA) Clin. Cosmet. Investig. Dermatol. 2022;15:997–1019. doi: 10.2147/CCID.S359813. - DOI - PMC - PubMed
    1. Narins R.S., Baumann L., Brandt F.S., Fagien S., Glazer S., Lowe N.J., Monheit G.D., Rendon M.I., Rohrich R.J., Werschler W.P. A randomized study of the efficacy and safety of injectable poly-l-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J. Am. Acad. Dermatol. 2010;62:448–462. doi: 10.1016/j.jaad.2009.07.040. - DOI - PubMed
    1. Bohnert K., Dorizas A., Lorenc P., Sadick N.S. Randomized, controlled, multicentered, double-blind investigation of injectable poly-l-lactic acid for improving skin quality. Dermatol. Surg. 2019;45:718–724. doi: 10.1097/DSS.0000000000001772. - DOI - PubMed
    1. Fitzgerald R., Vleggaar D. Facial volume restoration of the aging face with poly-l-lactic acid. Dermatol. Ther. 2011;24:2–27. doi: 10.1111/j.1529-8019.2010.01375.x. - DOI - PubMed
    1. Carey D.L., Baker D., Rogers G.D., Petoumenos K., Chuah J., Easey N., Machon K., Cooper D.A., Emery S., Carr A. A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy. JAIDS J. Acquir. Immune Defic. Syndr. 2007;46:581–589. doi: 10.1097/QAI.0b013e318158bec9. - DOI - PubMed

LinkOut - more resources